Treatment of Back Pain Using Transcutaneous Magnetic Stimulation (TCMS)
Primary Purpose
Lower Back Pain
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Fischell Transcutaneous Magnetic Stimulation Pain Treatment Device
Placebo
Sponsored by
About this trial
This is an interventional treatment trial for Lower Back Pain focused on measuring Transcutaneous Magnetic Stimulation, placebo
Eligibility Criteria
Inclusion Criteria:
- Adult, age >18 years of age
- Prescription pharmacologic treatment is insufficient for treatment of pain
- Pain duration of ≥ 6 months
- Pain limits physical activity
- Pain occurs daily
- Chronic low back pain, with or without leg pain, associated with MRI or other imaging study consistent with lumbo-sacral spine disease with or without nerve compression
- Pain intensity ≥ 5 at the time of enrollment a a self-reported pain score of ≥ 4 over the 7 preceding days.
Exclusion Criteria:
- Life expectancy ≤ 6 months for any reason
- Oral opiate dosing or type of opioid that has changed in past 12 months
- Received intraspinal (e.g., epidural, intrathecal) medication in the past 6 months
- Use of intravenous pain medication in the past 6 months
- Active use of a transcutaneous electrical nerve stimulator (TENS) [within 30 days]
- History of seizures
- History of implanted medical device, cardiac pacemaker or implantable cardiac defibrillator, or other implant (Cochlear etc)
- History of cardiac dysrhythmias
- Member of vulnerable population
- Current or potential legal action of disability claim related to back pain
- Body Mass Index (BMI) >35
- Another pain condition that might confound results, including back pain above the waistline
- Women of child-bearing potential
- Inability to undergo study assessments or complete questionnaires independently
- Metal objects in the body (i.e. Aneurysm clip, bullet fragment)
- Active psychological co-morbidites (i.e. uncontrolled schizophrenia)
Sites / Locations
- La Toya Stubbs
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Placebo Comparator
Arm Label
Transcutaneous Magnetic Stimulation
Sham Device
Arm Description
Transcutaneous Magnetic Stimulation
Sham Device
Outcomes
Primary Outcome Measures
Immediate Pain Measured by Numeric Pain Rating Scale (NPRS)
Immediate relief measured by Numeric Pain Rating Scale (NPRS)
Scale from 0-10 0=No pain 10= Worse possible pain
Secondary Outcome Measures
Durable Pain Measured by Numeric Pain Rating Scale (NPRS)
Durable pain relief measured by Numeric Pain Rating Scale (NPRS) 0= No pain 10= Worse imaginable pain
Full Information
NCT ID
NCT02421757
First Posted
April 10, 2015
Last Updated
October 26, 2021
Sponsor
University of Maryland, Baltimore
1. Study Identification
Unique Protocol Identification Number
NCT02421757
Brief Title
Treatment of Back Pain Using Transcutaneous Magnetic Stimulation (TCMS)
Official Title
Treatment of Back Pain Using Transcutaneous Magnetic Stimulation (TCMS)
Study Type
Interventional
2. Study Status
Record Verification Date
October 2021
Overall Recruitment Status
Completed
Study Start Date
August 22, 2016 (Actual)
Primary Completion Date
June 22, 2017 (Actual)
Study Completion Date
June 22, 2017 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Maryland, Baltimore
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Device Product Not Approved or Cleared by U.S. FDA
Yes
Data Monitoring Committee
No
5. Study Description
Brief Summary
This is a single-site, randomized, Single-blinded, placebo-controlled, trial of Transcutaneous Magnetic Stimulation (TCMS) for the treatment of lower back pain. TCMS will be applied locally to the back in the location of a patient's pain.
Detailed Description
Approximately one third of Americans suffer from acute and chronic pain and pain has been called a silent epidemic. Treatment of pain often involves opioid medications with a significant potential for abuse, addiction and adverse reactions such as respiratory depression and death. Magnetic brain stimulation has been used for the treatment of pain. There are reports of its use in phantom-limb pain and in the treatment of central and peripheral pain syndromes.
The study will evaluate whether an experimental medical device (Fischell TCMS Pain Treatment Device) that emits pulses of a brief, intense magnetic field will relieve pain in the lower back. Transcutaneous Magnetic Stimulation (TCMS) is the name of this method of delivering magnetic pulses through the skin. TCMS has been approved by the FDA for peripheral nerve stimulation, treatment of migraine headaches and for depression but this type of device has not been studied scientifically for the treatment of back pain. No significant adverse reactions or side effects have been reported with the use of magnetic stimulation for headache treatment. Some patients who have migraine headaches have excellent pain relief with the magnetic treatment even if they do not get pain relief with medications. Other patients do not have headache relief with magnetic treatment. The current use of TCMS applied to the head requires special equipment and multiple treatment sessions. TCMS applied peripherally is easier to do, and may require fewer treatment sessions to achieve pain relief. Non-invasive treatment of pain would represent a significant advance in the field especially if its use both successfully treated pain and resulted in the reduction or elimination in the need for opioid medications.
The investigators do not know whether magnetic treatment will relieve back pain so the investigators will test this by applying a powerful electromagnet to the area of the back having pain. In some patients, the magnet will be turned on, but in other patients the magnet will not be turned on. Neither patients nor patient's treating doctor will know whether the magnet was turned on or not, although the study team will know which patients received treatment with magnetic pulses. The effect on pain will be recorded periodically for 2 days. If the patients' reported pain is reduced by having the magnet turned on compared to patients' who do not have the magnet turned on, then the magnet may have reduced the pain. Additional studies in patients will be needed to be sure that the magnet therapy is reducing low back pain.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Lower Back Pain
Keywords
Transcutaneous Magnetic Stimulation, placebo
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
20 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Transcutaneous Magnetic Stimulation
Arm Type
Experimental
Arm Description
Transcutaneous Magnetic Stimulation
Arm Title
Sham Device
Arm Type
Placebo Comparator
Arm Description
Sham Device
Intervention Type
Device
Intervention Name(s)
Fischell Transcutaneous Magnetic Stimulation Pain Treatment Device
Intervention Description
Transcutaneous Magnetic Stimulation
Intervention Type
Device
Intervention Name(s)
Placebo
Other Intervention Name(s)
Fischell Transcutaneous Magnetic Stimulation Pain Treatment Device (TCMS Placebo)
Intervention Description
The placebo Transcutaneous device
Primary Outcome Measure Information:
Title
Immediate Pain Measured by Numeric Pain Rating Scale (NPRS)
Description
Immediate relief measured by Numeric Pain Rating Scale (NPRS)
Scale from 0-10 0=No pain 10= Worse possible pain
Time Frame
60 minutes
Secondary Outcome Measure Information:
Title
Durable Pain Measured by Numeric Pain Rating Scale (NPRS)
Description
Durable pain relief measured by Numeric Pain Rating Scale (NPRS) 0= No pain 10= Worse imaginable pain
Time Frame
30 days
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Adult, age >18 years of age
Prescription pharmacologic treatment is insufficient for treatment of pain
Pain duration of ≥ 6 months
Pain limits physical activity
Pain occurs daily
Chronic low back pain, with or without leg pain, associated with MRI or other imaging study consistent with lumbo-sacral spine disease with or without nerve compression
Pain intensity ≥ 5 at the time of enrollment a a self-reported pain score of ≥ 4 over the 7 preceding days.
Exclusion Criteria:
Life expectancy ≤ 6 months for any reason
Oral opiate dosing or type of opioid that has changed in past 12 months
Received intraspinal (e.g., epidural, intrathecal) medication in the past 6 months
Use of intravenous pain medication in the past 6 months
Active use of a transcutaneous electrical nerve stimulator (TENS) [within 30 days]
History of seizures
History of implanted medical device, cardiac pacemaker or implantable cardiac defibrillator, or other implant (Cochlear etc)
History of cardiac dysrhythmias
Member of vulnerable population
Current or potential legal action of disability claim related to back pain
Body Mass Index (BMI) >35
Another pain condition that might confound results, including back pain above the waistline
Women of child-bearing potential
Inability to undergo study assessments or complete questionnaires independently
Metal objects in the body (i.e. Aneurysm clip, bullet fragment)
Active psychological co-morbidites (i.e. uncontrolled schizophrenia)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Peter Rock, MD
Organizational Affiliation
University of Maryland, Baltimore
Official's Role
Principal Investigator
Facility Information:
Facility Name
La Toya Stubbs
City
Baltimore
State/Province
Maryland
ZIP/Postal Code
21201
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Treatment of Back Pain Using Transcutaneous Magnetic Stimulation (TCMS)
We'll reach out to this number within 24 hrs